In support with our findings, there is now a compelling body of evidence that TRAIL is a unique death ligand for induction of fulminant apoptotic effects in various human cancer cell types, including HCC, while showing only negligible effects on normal cells including normal hepatocytes [18–20, 51]. Here, TNFSF10 is linked to hepatocellular carcinoma.